Medicaid Subscription-Based Payment Models and Implications for Access to Hepatitis C Medications-Reference-Cited by-同舟云学术

Medicaid Subscription-Based Payment Models and Implications for Access to Hepatitis C Medications

Published:2021-08-27 Issue:8 Volume:2 Page:e212291
ISSN:2689-0186
Container-title:JAMA Health Forum
language:en
Short-container-title:JAMA Health Forum

Author:

Auty Samantha G.¹,Shafer Paul R.¹,Griffith Kevin N.²

Affiliation:

1. Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, Massachusetts

2. Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee

Publisher

American Medical Association (AMA)

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://jamanetwork.com/journals/jama-health-forum/articlepdf/2783656/auty_2021_oi_210037_1630012074.28555.pdf

Reference35 articles.

1. Estimating the year each state in the United States will achieve the World Health Organization’s Elimination targets for hepatitis C.;Sulkowski;Adv Ther,2021

2. Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States.;Rosenthal;Infect Agent Cancer,2016

3. Direct economic burden of chronic hepatitis C virus in a United States managed care population.;Davis;J Clin Gastroenterol,2011

4. Differences between managed care and fee-for-service Medicaid in the use of generics for high-rebate drugs: the cases of insulin glargine and glatiramer.;Hernandez;J Manag Care Spec Pharm,2020

5. Restrictions of hepatitis C treatment for substance-using Medicaid patients: cost versus ethics.;Liao;Am J Public Health,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in Use of Hepatitis C Direct-Acting Antivirals After Access Restrictions Were Eased by State Medicaid Programs;JAMA Health Forum;2024-04-05

2. Drug development for major chronic health conditions—aligning with growing public health needs: Proceedings from a multistakeholder think tank;American Heart Journal;2024-04

3. Advancing Hepatitis C Elimination through Opt-Out Universal Screening and Treatment in Carceral Settings, United States;Emerging Infectious Diseases;2024-03

4. Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugs;Drug and Alcohol Dependence Reports;2024-03

5. High Seroprevalence of Hepatitis C Virus Among Cisgender Women Who Exchange Sex in the Seattle, Washington Area;Substance Use & Addiction Journal;2023-12-29